Relationship of the hematopoietic cycle to the combined activities of a
stimulator and a short-lived inhibitor
PJ Burke and JE Karp
Substances that circulate in the blood following drug-induced bone marrow
aplasia produce a biphasic curve of DNA synthesis in cells in liquid and
semisolid cultures which reflect relative concentrations of these growth
regulators of hematopoiesis. This net effect magnified by induced marrow
failure in human, rat, and mouse is a sinusoidal curve that is the
reciprocal of the WBC. Generated in the bone marrow, humoral stimulating
activity (HSA) produces peak growth of colonies in agar (CFU-GM) during the
proliferative phase of bone marrow recovery, whereas humoral inhibitory
activity (HIA), present at the time of marrow maturation, suppresses colony
growth. Split femurs from rats given cyclophosphamide (CY) and killed at
regular intervals condition media that affect DNA synthesis in a fashion
similar to that of HSA-HIA in the rats' sera. In Dexter cultures, HSA is
derived from the adherent rather than the hematopoietic cell, whereas HIA
is produced by that nonadherent cell. Animals treated with a lethal dose of
busulfan (BU) produce large amounts of HSA in vivo until death. Those
transplanted with adherent bone marrow cells depleted of hematopoietic
cells on day 1 after BU also die, whereas those given nonadherent marrow
cells survive and generate HIA at the time of bone marrow recovery. HSA and
media conditioned by bone marrow stromal cells causes an increase in spleen
colonies (CFU-S), as does HIA. These studies support the contention that
the net effect of putative regulators of hematopoiesis, measured in the
drug-perturbed state, consist of a constantly present stimulator emanating
from bone marrow stroma, and a variable inhibitor produced by maturing
hematopoietic bone marrow cells.
Volume 69,
Issue 2,
pp. 513-521,
02/01/1987
Copyright © 1987 by The American Society of Hematology